Epigenetics.TV

Next up for CRISPR: Gene editing for the masses? Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.

Lifestyle Choices to Transform Your Gene Activity By Deepak Chopra, MD and Rudolph E. Tanzi, PhD When people think about genes, they tend to apply the words good or bad to them. Someone with talent or